Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.
"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":93,"sourceGroups":{"omim":4,"orphanet":89,"published":0}},"features":[{"hpoId":"HP:0002027","label":"Abdominal pain","primary":false},{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":false},{"hpoId":"HP:0012135","label":"Abnormal granulocytopoietic cell morphology","primary":false},{"hpoId":"HP:0012143","label":"Abnormal megakaryocyte morphology","primary":false},{"hpoId":"HP:0025035","label":"Abnormal proerythroblast morphology","primary":false},{"hpoId":"HP:0012129","label":"Abnormality of bone marrow stromal cells","primary":false},{"hpoId":"HP:0012145","label":"Abnormality of multiple cell lineages in the bone marrow","primary":false},{"hpoId":"HP:0000168","label":"Abnormality of the gingiva","primary":false},{"hpoId":"HP:0004845","label":"Acute monocytic leukemia","primary":false},{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":false},{"hpoId":"HP:0004820","label":"Acute myelomonocytic leukemia","primary":false},{"hpoId":"HP:0004836","label":"Acute promyelocytic leukemia","primary":false},{"hpoId":"HP:0030955","label":"Addictive alcohol use","primary":false},{"hpoId":"HP:0001903","label":"Anemia","primary":false},{"hpoId":"HP:0001785","label":"Ankle swelling","primary":false},{"hpoId":"HP:0002039","label":"Anorexia","primary":false},{"hpoId":"HP:0031020","label":"Bone marrow hypercellularity","primary":false},{"hpoId":"HP:0005528","label":"Bone marrow hypocellularity","primary":false},{"hpoId":"HP:0002653","label":"Bone pain","primary":false},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":false},{"hpoId":"HP:0011787","label":"Central hypothyroidism","primary":false},{"hpoId":"HP:0025289","label":"Cervical lymphadenopathy","primary":false},{"hpoId":"HP:0031035","label":"Chronic infection","primary":false},{"hpoId":"HP:0001882","label":"Decreased total leukocyte count","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0025420","label":"Diffuse alveolar hemorrhage","primary":false},{"hpoId":"HP:0005521","label":"Disseminated intravascular coagulation","primary":false},{"hpoId":"HP:0002094","label":"Dyspnea","primary":false},{"hpoId":"HP:0031364","label":"Ecchymosis","primary":false},{"hpoId":"HP:0000421","label":"Epistaxis","primary":false},{"hpoId":"HP:0012133","label":"Erythroid hypoplasia","primary":false},{"hpoId":"HP:0002875","label":"Exertional dyspnea","primary":false},{"hpoId":"HP:0012378","label":"Fatigue","primary":false},{"hpoId":"HP:0001945","label":"Fever","primary":false},{"hpoId":"HP:0100758","label":"Gangrene","primary":false},{"hpoId":"HP:0000225","label":"Gingival bleeding","primary":false},{"hpoId":"HP:0000212","label":"Gingival overgrowth","primary":false},{"hpoId":"HP:0000790","label":"Hematuria","primary":false},{"hpoId":"HP:0001931","label":"Hypochromic anemia","primary":false},{"hpoId":"HP:0011900","label":"Hypofibrinogenemia","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0031386","label":"Increased micromegakaryocyte count","primary":false},{"hpoId":"HP:0001880","label":"Increased total eosinophil count","primary":false},{"hpoId":"HP:0001974","label":"Increased total leukocyte count","primary":false},{"hpoId":"HP:0100827","label":"Increased total lymphocyte count","primary":false},{"hpoId":"HP:0003419","label":"Low back pain","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0031385","label":"Megakaryocyte nucleus hypolobulation","primary":false},{"hpoId":"HP:0100608","label":"Metrorrhagia","primary":false},{"hpoId":"HP:0005508","label":"Monoclonal elevation of circulating IgM concentration","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0011974","label":"Myelofibrosis","primary":false},{"hpoId":"HP:0100520","label":"Oliguria","primary":false},{"hpoId":"HP:0030140","label":"Oral cavity bleeding","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0001876","label":"Pancytopenia","primary":false},{"hpoId":"HP:0100539","label":"Periorbital edema","primary":false},{"hpoId":"HP:0000967","label":"Petechiae","primary":false},{"hpoId":"HP:0031245","label":"Productive cough","primary":false},{"hpoId":"HP:0001730","label":"Progressive hearing impairment","primary":false},{"hpoId":"HP:0000979","label":"Purpura","primary":false},{"hpoId":"HP:0004828","label":"Refractory anemia with ringed sideroblasts","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0010280","label":"Stomatitis","primary":false},{"hpoId":"HP:0001482","label":"Subcutaneous nodule","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false},{"hpoId":"HP:0002321","label":"Vertigo","primary":false},{"hpoId":"HP:0001824","label":"Weight loss","primary":false}],"ledeHtml":"Cytogenetically normal acute myeloid leukemia (CN-AML) is one form of a cancer of the blood-forming tissue (bone marrow) called acute myeloid leukemia. In normal bone marrow, early blood cells called hematopoietic stem cells develop into several types of blood cells: white blood cells (leukocytes) that protect the body from infection, red blood cells (erythrocytes) that carry oxygen, and platelets (thrombocytes) that are involved in blood clotting. In acute myeloid leukemia, the bone marrow makes large numbers of abnormal, immature white blood cells called myeloid blasts. Instead of developing into normal white blood cells, the myeloid blasts develop into cancerous leukemia cells. The large number of abnormal cells in the bone marrow interferes with the production of functional white blood cells, red blood cells, and platelets.","mondoId":"MONDO:0018874","records":[{"frequencyKind":"range","key":"033da2d1ca743ca3d82ac53a30b63cc3a5b4b6086baae5eebc1b0d5038d5b3d6","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002094","is_excluded":false,"label":"Dyspnea","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"08d4fb049c6ab3265ab9fe841ea05f0917e820f60463feb5b82cbcc8229d161d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011900","is_excluded":false,"label":"Hypofibrinogenemia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0b7b09bd3eb956339e8a330fc91fc56ebc36da76bf73bc6f98cf1763e920d237","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001730","is_excluded":false,"label":"Progressive hearing impairment","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0c559beaafbe1e5ebdb43f1e16f268e716e6acc85ef71a5c9aeae4924b2346f1","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e5c8bccdc735d4eabfcd0e6847690d764660cb93f34c0ad0d36a4eea7319058","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012133","is_excluded":false,"label":"Erythroid hypoplasia","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"121d377f3f8eb23642869f4fdec96d7e1e5df2f1fe64b5379d31f6b8334e32d2","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031245","is_excluded":false,"label":"Productive cough","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"14b176ac905df8fc8e45a9f92fd4924875dfcbf3418498845527c33312c34c44","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001882","is_excluded":false,"label":"Decreased total leukocyte count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"169e36d7195258bf4a21c53c1bd7d6dbdf2d1e58808b4b65db319b32def45050","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100827","is_excluded":false,"label":"Increased total lymphocyte count","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"19e2abb185ef89596589029856bb6734a7cf7732b4b286d6e8c1e4b8eb3686e5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030955","is_excluded":false,"label":"Addictive alcohol use","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1e73deccc63f8984952e88c124338f5b23ff2ab71fe10c59ebc15fc2129ae391","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005528","is_excluded":false,"label":"Bone marrow hypocellularity","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2112a7f009414aded8d80214d921b6547c8e2326bb990cc6f55a35b8408c5de1","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001882","is_excluded":false,"label":"Decreased total leukocyte count","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"22206255aa0aecb8b4b1420193350998507b1e408a6a6e2a9744ddf8296b64a5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2cdd0bee8210fa71eabacdd67ddacb9e53406e12ba7809fefdbb566d1349b57f","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f3980a39e28b0ba4e0ef19e37728b70df9fbb1787cdad04a7a210caee343185","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31e8363bb72c6dfff4c6ea53003ad021da1b24093134ff86cde54ba453dd9818","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025289","is_excluded":false,"label":"Cervical lymphadenopathy","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"35ea6a9acfa90b2ccc82bdc2a8bbe28ff9694f9458a25da6d1262be6649ecf79","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002321","is_excluded":false,"label":"Vertigo","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"375f2109f058ede5339a4176112f0c2805666e46a2061ddd652e7b4ab9189ec6","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002875","is_excluded":false,"label":"Exertional dyspnea","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"381f9bb4a05562ffb5964779a3701a0fd0c9a7b8a863f5325c75742987af21fb","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100539","is_excluded":false,"label":"Periorbital edema","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3837ee6353c1742888d93d05e93f680ecce110741490976b078b0a3b75b6e2e6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001785","is_excluded":false,"label":"Ankle swelling","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a0ef7ad91d2e7ec68d2b88f03a62ec81ce96110fb356b404091b8df758cfd50","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004820","is_excluded":false,"label":"Acute myelomonocytic leukemia","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3ce8a2b2da46ff38634f6c698d2bce0586cb298844c000004b9e374eef448899","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612376","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012135","is_excluded":false,"label":"Abnormal granulocytopoietic cell morphology","onset_id":null,"reference":"OMIM:612376","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3d48774bfc942ddb1d3d83b578e4a27bf727d129541c691c28e117d8dd34b86c","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d50966e2b6a9d273edd9fccbf9d179d58f73e2c6d73ea64e2bc3ae75eddf618","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001482","is_excluded":false,"label":"Subcutaneous nodule","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"444a754e8ea3697074225f6a3cfdbead5911cc0a52baebc91fbe48ac781f98ab","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4582150e0b0d424c96e1d8446fc01400739661599bb7bda9b8918d77d7fc6c32","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46fbd68a6ae55f88158d66f1627587733fffc14b93211b49fc387536641be1df","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4cb223a97d4e88b05a6d3b4f6456e37903f7c6e5437f0e1051ff8d507d18c2e5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e761e1d3802f6af330e8a67cdce1f3fcb6d7e8191ab56726037b0d8c8d3ddb4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031385","is_excluded":false,"label":"Megakaryocyte nucleus hypolobulation","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4ff13a75490de65b3d81a47df54fea1bb8a1826eebe7cc2e782e0f21e7c61bdd","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"50c55780117952a0de7c4cc8cc334ba1435d2f3acb2526ce317821b372ee287a","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031364","is_excluded":false,"label":"Ecchymosis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"51911830f7c5ed4a3a24dbddc8a32d7b813d55941c57658bf4a006bc2f7fe678","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005528","is_excluded":false,"label":"Bone marrow hypocellularity","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5f08e1037a0b1877b5a0d16f98ce16d2d445682b180af2aeef1329cc6d6facfe","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000212","is_excluded":false,"label":"Gingival overgrowth","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6134dff885eb992e11ba88a452b6d8a290d9be423cec8f6721c115f90949cfda","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6616d3dae55c056f4aa23817c25c62d5b5239680cc7d46ee4a5ca6dcd32d43eb","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"662159a7c561857fde156ebdc665ef1037d94860d7a444474f145076b61033ca","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6669f95c7a5eb3a5eaa34178df6c93a93d7e2c058bdbce09660f5046659c9d06","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001876","is_excluded":false,"label":"Pancytopenia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6844795a1449c0b1432129177ae4fe0d61d3ed00d1d90eca01cdb885d853ba8c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6952ef34334549afbd0027074eb953c92c97ae376d9fced8c76a8bba9c5cc52d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6bb932ab34bb38faf441a282a466e0916300cac1e7da77c16ddff7454475f105","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6be70faff8021adfeb0670ee1f801b726816c9bfb84421759249835b64ae0fd7","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001931","is_excluded":false,"label":"Hypochromic anemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6d52b0b4e1ae72749a31850cc28f44d04288fecb0f4671e4aaf6ff8035a2ed9e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f8422671d7b0ed473428ed92d8b1189d74d730caefb4e7ddbc4b9d9e2655a0d","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002027","is_excluded":false,"label":"Abdominal pain","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6fea2717e96159165c3226311917add66a69620ecdeb0de47037dac681594e38","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:601626","disease_name":"Leukemia, acute myeloid","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"OMIM:601626","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7041c85ffcbd2f6a864193f8cbbfcdcc21c3b626db7a1c8eb22694bfb04cf5fc","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"72e03ac9c9a012e4336d2a2f38b13e0b7d7d512da03bf6af52b7d25276696bf8","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000225","is_excluded":false,"label":"Gingival bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7b46ed38376ea195ab7c2dd1985ce4dc23c37a33725644de4ec7fbb9cefaa126","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031035","is_excluded":false,"label":"Chronic infection","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8317f47ff695f3945c897b10eaff653370c6348aa034404f21210c45fc7e10c4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005521","is_excluded":false,"label":"Disseminated intravascular coagulation","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8452cbfa647761c2c59c088c565b55fc32c6ed10ea8f05024c27eda242a780b2","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002039","is_excluded":false,"label":"Anorexia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88fc991efa4fe9bbd6832e3f301e0a96bba33c8ae99afc9b045a209477e78c8c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0004845","is_excluded":false,"label":"Acute monocytic leukemia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"906bf97fbf5d07577c4f6a9ae514c92dde4817c7af7180c6ee9aa529d3925b44","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005508","is_excluded":false,"label":"Monoclonal elevation of circulating IgM concentration","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"90b646bb5d7eb72e73726e483b0b2dfd2d23da398953d4ecd22b13eb1cd704e4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001974","is_excluded":false,"label":"Increased total leukocyte count","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"995ec685e04fbb205705dbcc239e0b63da1ef14e5fc0ddff1b090f25607d89c7","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012143","is_excluded":false,"label":"Abnormal megakaryocyte morphology","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3657e90af1ce2e165585be4ad4f281465553cd87d259a5771312284a4d05879","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a5063b9a991bf5137705e4a45f1e739514dfd8be0782bdacfdb2f705624f38b4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001876","is_excluded":false,"label":"Pancytopenia","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a6545d0c79b775839e33fff3912b01caf144960f3eb6cc1a3eaa6631a05751c3","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002039","is_excluded":false,"label":"Anorexia","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"acf76590efe8e020d9d872bff34c8e1866046a68255565de977f1cc9ace4c5ad","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000168","is_excluded":false,"label":"Abnormality of the gingiva","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ad9532a612e8ae8f1faadaa543721381e9683ae1a910adca2559bd4bf67b4945","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000790","is_excluded":false,"label":"Hematuria","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae492f34b7352291ccf7fa7174f78254bf44ba6655cbb0e614c9e584e9731a31","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001880","is_excluded":false,"label":"Increased total eosinophil count","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae741df01b807c7dec5c35bd4fb58608b5fa1c267b946de5441e55bdfaec9042","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b1014760bf0a0f0283e99336c9cad9e218799f937d4662294341ef05c8cc1d9a","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:151380","disease_name":"Leukemia, acute monocytic","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0004845","is_excluded":false,"label":"Acute monocytic leukemia","onset_id":null,"reference":"OMIM:151380","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b2d4558550109b99f387133895c0755578b3653061705b9239af4bee720a13da","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003419","is_excluded":false,"label":"Low back pain","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3b1ec80e2d916959e9ce770bf9e1c3eced2b8582fabd6c5c9fa85b159377aa6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b5798b2e36bc25371bba4f84ec9b82962dbd8bb41121cb73c7d3da1c6180abe8","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612376","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004836","is_excluded":false,"label":"Acute promyelocytic leukemia","onset_id":null,"reference":"OMIM:612376","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b68f6d82d07d245f685cab80b8bacd6a48c8ab8a70f5c002bd4d73502388541c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bed6a36f4f64e1c3da278518654233d6c1372aff6c233d5cf3991657d587720f","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025420","is_excluded":false,"label":"Diffuse alveolar hemorrhage","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0eac67176318f38aed4cbbecb44992941f7a14a5eff4d3a0e975b4c779e36f0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025035","is_excluded":false,"label":"Abnormal proerythroblast morphology","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c21d90cca5ff57b0fe113429b15aa8682f65b28e4d43216b60a785c18f4c15f7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100520","is_excluded":false,"label":"Oliguria","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c2a555d7ec96f6af59e0e748181330b58bb0363e8f54b3a8883aa8ea2fc3976e","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012129","is_excluded":false,"label":"Abnormality of bone marrow stromal cells","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c38287665fa4615987068c50f360d3dba901ba198efe48f3c185b3008d405be0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004828","is_excluded":false,"label":"Refractory anemia with ringed sideroblasts","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6027048809e00dadd6395a8477a34e24d3b9ee670c13bf18c31415cb8be066d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030140","is_excluded":false,"label":"Oral cavity bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c6518eed2134e0ded34618a24a5e97afac30e2f9e369f0b535d77f4840ebd34d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011974","is_excluded":false,"label":"Myelofibrosis","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8b100a6faf9cb82a21ade8d20fbd563d7f780429143f0caf72b9334861fc5c0","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012378","is_excluded":false,"label":"Fatigue","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8d36e6961b01c4f48dc06cab2f9b1ea1aff14f56e6d0498a733f9bcecfad5e9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100608","is_excluded":false,"label":"Metrorrhagia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c973a848482a83817d652342b0e2378193411071b0711e403e1bec2e2689911a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb1b521cf931a84b5252c80ba1cfb68bc2829810d2934cf04f840e34556f32d4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001945","is_excluded":false,"label":"Fever","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb8c20e17ccc85bdcf4b8163c902ccf6038066ef2daca3d246c781097a092ec3","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ccabe310ab94cdb893bea3337718fad54f1f103fd2569b3bc15f420f8eacc890","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002653","is_excluded":false,"label":"Bone pain","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d0e45ffa99b6e0ac0a4e2dd04ec7f3520d5e0bd03844e09bdf9dbe48254a294b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d0f4ce48e5107be62e1ecd467f6a9903c50775e0cb27ebd71172375d4910b919","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100827","is_excluded":false,"label":"Increased total lymphocyte count","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d239e9b6e2a24922f37ad96684c7a6d4c461449a2cf5c9026c6c172064e8df6c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031386","is_excluded":false,"label":"Increased micromegakaryocyte count","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d2fbd0d1d6ee520b982dc411432d32882c995993dc8c9194dc84f3cd2433716c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d321944606d57d33ef2eb14fa4626ed6152077b3003c71efdbdfb7c2fda579c6","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d49519618e063933c77e8243cec9cb14ac8e3520042643086b7567153b3208da","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010280","is_excluded":false,"label":"Stomatitis","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5342181b702784cdbaab66f73ead3b13c60c574829dbbe95273fef08f846f8f","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d655c77ed42ad927e5bce5678ef66b2e378df36740cd68f6d1d1067f58df21a0","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:517","disease_name":"Acute myelomonocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001824","is_excluded":false,"label":"Weight loss","onset_id":null,"reference":"ORPHA:517","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da3de2ec250f79d6269a99784b0ea387e3b55237f1b0acf1865fdfabcd3a67b0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:318","disease_name":"Acute erythroid leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001876","is_excluded":false,"label":"Pancytopenia","onset_id":null,"reference":"ORPHA:318","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de60384dda2bd470814fb0b5f902be4e9eb25b59f270126b6cc7774999c84b05","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012145","is_excluded":false,"label":"Abnormality of multiple cell lineages in the bone marrow","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"de69154c4c9a73ee857bb5ee29ddf390e70eba16387b31878b7df1e802760278","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002875","is_excluded":false,"label":"Exertional dyspnea","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0e7f377959e797073eab7c1c10a4f7cdbea4a5c64289413a0d8441e526223b4","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100758","is_excluded":false,"label":"Gangrene","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e365d0743761d288bd383deb759f1e9f74d2d34adba6dd4cd0e4051e02980ef3","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000979","is_excluded":false,"label":"Purpura","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e6500c523e05ab6e691e9931a9df6e22657ac31dc89cf34222610f7c0fe4a650","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:514","disease_name":"Acute monoblastic/monocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011787","is_excluded":false,"label":"Central hypothyroidism","onset_id":null,"reference":"ORPHA:514","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f16e5d37afe5c70e01b73ce9d96704e8d069d13e0594fb73715c33d8f2811368","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86843","disease_name":"Acute panmyelosis with myelofibrosis","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"ORPHA:86843","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f75d0fbd97b12926843751c73cf0eade830999b7fab17de3d51c1dc86d5f82a0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:520","disease_name":"Acute promyelocytic leukemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"ORPHA:520","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"Some people with AML have large chromosomal rearrangements. AML is classified as "cytogenetically normal" when standard testing does not detect large chromosomal abnormalities. However, in people with CN-AML, genetic testing of cancer cells often reveals changes within one or more genes. Identifying specific genetic changes can help predict the course and outcome of an individual’s CN-AML (prognosis) and determine the most appropriate therapies.
Genetic changes that contribute to disease are called pathogenic variants. Pathogenic variants in many different genes have been associated with CN-AML. The genes that are associated with CN-AML provide instructions for producing proteins that are involved in cell growth and division (proliferation), cell maturation (differentiation), and cell survival. The pathogenic variants in these genes are typically acquired during a person’s lifetime (somatic) and are only present in cancer cells.
Specific gene variants are associated with varying risks of developing CN-AML. Pathogenic variants in the following genes are common in people with CN-AML:
- FLT3
- CEBPA
- NPM1
- IDH1
- IDH2
The somatic variants in these and other genes that are associated with CN-AML disrupt the proliferation, differentiation, or survival of hematopoietic stem cells. Sometimes, more than one of these processes is disrupted. These changes likely contribute to the overproduction of abnormal, immature white blood cells that is seen in people with CN-AML.
The protein produced from the FLT3 gene plays an important role in cell signaling pathways that are directly involved in cell proliferation and differentiation, while the protein produced from the CEBPA gene helps regulate gene activity (expression). The protein made from the NPM1 gene shuttles between the nucleus and the surrounding fluid (the cytoplasm). Through its interactions with other proteins, it plays an important role in tumor suppression, which means that it keeps cells from proliferating in an uncontrolled way. The proteins produced by the IDH1 and IDH2 genes help produce energy for bone marrow cells to grow and mature.
Typically, people with CN-AML have pathogenic variants in more than one gene. For example, affected individuals with a variant in the NPM1 gene also frequently have a somatic variant in the FLT3 gene, both of which are likely involved in the development of cancer. In addition, environmental factors such as smoking or exposure to radiation increase an individual's risk of developing CN-AML.
","key":"forms","title":"What causes Cytogenetically normal acute myeloid leukemia?"},{"bodyHtml":"People with CN-AML have a shortage of all types of mature blood cells: a shortage of white blood cells (leukopenia) leads to increased susceptibility to infections, a low number of red blood cells (anemia) causes fatigue and weakness, and a reduction in the amount of platelets (thrombocytopenia) can result in easy bruising and abnormal bleeding. Other symptoms of CN-AML may include fever and weight loss.
The age at which CN-AML begins ranges from childhood to late adulthood. CN-AML is said to be an intermediate-risk cancer because the prognosis varies: some affected individuals respond well to normal treatment while others may require stronger treatments. The age at which the condition begins and the prognosis are affected by the specific genetic factors involved in the condition.
Source: MedlinePlus Genetics
Familial acute myeloid leukemia with mutated CEBPA is one form of a cancer of the blood-forming tissue (bone marrow) called acute myeloid leukemia. In normal bone marrow, early blood cells called hematopoietic stem cells develop into several types of blood cells: white blood cells (leukocytes) that protect the body from infection; red blood cells (erythrocytes) that carry oxygen; and platelets (thrombocytes), which are involved in blood clotting. In acute myeloid leukemia, the bone marrow makes large numbers of abnormal, immature white blood cells called myeloid blasts. Instead of developing into normal white blood cells, the myeloid blasts develop into cancerous leukemia cells. The large number of abnormal cells in the bone marrow interferes with the production of functional white blood cells, red blood cells, and platelets.
People with familial acute myeloid leukemia with mutated CEBPA have a shortage of white blood cells (leukopenia), leading to increased susceptibility to infections. A low number of red blood cells (anemia) also occurs in this disorder, resulting in fatigue and weakness. Affected individuals also have a reduction in the amount of platelets (thrombocytopenia), which can result in easy bruising and abnormal bleeding. Other symptoms of familial acute myeloid leukemia with mutated CEBPA may include fever and weight loss.
While acute myeloid leukemia is generally a disease of older adults, familial acute myeloid leukemia with mutated CEBPA often begins earlier in life, and it has been reported to occur as early as age 4. Between 50 and 65 percent of affected individuals survive their disease, compared with 25 to 40 percent of those with other forms of acute myeloid leukemia. However, people with familial acute myeloid leukemia with mutated CEBPA have a higher risk of having a new primary occurrence of this disorder after successful treatment of the initial occurrence.
As its name suggests, familial acute myeloid leukemia with mutated CEBPA is caused by mutations in the CEBPA gene that are passed down within families. These inherited mutations are present throughout a person's life in virtually every cell in the body.
The CEBPA gene provides instructions for making a protein called CCAAT enhancer-binding protein alpha. This protein is a transcription factor, which means that it attaches (binds) to specific regions of DNA and helps control the activity of certain genes. It is believed to act as a tumor suppressor, helping to prevent cells from growing and dividing too rapidly or in an uncontrolled way.
CEBPA gene mutations that cause familial acute myeloid leukemia with mutated CEBPA result in a shorter version of CCAAT enhancer-binding protein alpha. This shorter version is produced from one copy of the CEBPA gene in each cell, and it is believed to interfere with the tumor suppressor function of the normal protein produced from the second copy of the gene. Absence of the tumor suppressor function of CCAAT enhancer-binding protein alpha is believed to disrupt the regulation of blood cell production in the bone marrow, leading to the uncontrolled production of abnormal cells that occurs in acute myeloid leukemia.
In addition to the inherited mutation in one copy of the CEBPA gene in each cell, most individuals with familial acute myeloid leukemia with mutated CEBPA also acquire a mutation in the second copy of the CEBPA gene. The additional mutation, which is called a somatic mutation, is found only in the leukemia cells and is not inherited. The somatic CEBPA gene mutations identified in leukemia cells generally decrease the DNA-binding ability of CCAAT enhancer-binding protein alpha. The effect of this second mutation on the development of acute myeloid leukemia is unclear.
MedlinePlus: Familial acute myeloid leukemia with mutated CEBPA
Acute promyelocytic leukemia is a form of acute myeloid leukemia, a cancer of the blood-forming tissue (bone marrow). In normal bone marrow, hematopoietic stem cells produce red blood cells (erythrocytes) that carry oxygen, white blood cells (leukocytes) that protect the body from infection, and platelets (thrombocytes) that are involved in blood clotting. In acute promyelocytic leukemia, immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a shortage of normal white and red blood cells and platelets in the body, which causes many of the signs and symptoms of the condition.
People with acute promyelocytic leukemia are especially susceptible to developing bruises, small red dots under the skin (petechiae), nosebleeds, bleeding from the gums, blood in the urine (hematuria), or excessive menstrual bleeding. The abnormal bleeding and bruising occur in part because of the low number of platelets in the blood (thrombocytopenia) and also because the cancerous cells release substances that cause excessive bleeding.
The low number of red blood cells (anemia) can cause people with acute promyelocytic leukemia to have pale skin (pallor) or excessive tiredness (fatigue). In addition, affected individuals may heal slowly from injuries or have frequent infections due to the loss of normal white blood cells that fight infection. Furthermore, the leukemic cells can spread to the bones and joints, which may cause pain in those areas. Other general signs and symptoms may occur as well, such as fever, loss of appetite, and weight loss.
Acute promyelocytic leukemia is most often diagnosed around age 40, although it can be diagnosed at any age.
The mutation that causes acute promyelocytic leukemia involves two genes, the PML gene on chromosome 15 and the RARA gene on chromosome 17. A rearrangement of genetic material (translocation) between chromosomes 15 and 17, written as t(15;17), fuses part of the PML gene with part of the RARA gene. The protein produced from this fused gene is known as PML-RARα. This mutation is acquired during a person's lifetime and is present only in certain cells. This type of genetic change, called a somatic mutation, is not inherited.
The PML-RARα protein functions differently than the protein products of the normal PML and RARA genes. The protein produced from the RARA gene, RARα, is involved in the regulation of gene transcription, which is the first step in protein production. Specifically, this protein helps control the transcription of certain genes important in the maturation (differentiation) of white blood cells beyond the promyelocyte stage. The protein produced from the PML gene acts as a tumor suppressor, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. The PML-RARα protein interferes with the normal function of both the PML and the RARα proteins. As a result, blood cells are stuck at the promyelocyte stage, and they proliferate abnormally. Excess promyelocytes accumulate in the bone marrow and normal white blood cells cannot form, leading to acute promyelocytic leukemia.
The PML-RARA gene fusion accounts for up to 98 percent of cases of acute promyelocytic leukemia. Translocations involving the RARA gene and other genes have been identified in a few cases of acute promyelocytic leukemia.
Core binding factor acute myeloid leukemia (CBF-AML) is one form of a cancer of the blood-forming tissue (bone marrow) called acute myeloid leukemia. In normal bone marrow, early blood cells called hematopoietic stem cells develop into several types of blood cells: white blood cells (leukocytes) that protect the body from infection, red blood cells (erythrocytes) that carry oxygen, and platelets (thrombocytes) that are involved in blood clotting. In acute myeloid leukemia, the bone marrow makes large numbers of abnormal, immature white blood cells called myeloid blasts. Instead of developing into normal white blood cells, the myeloid blasts develop into cancerous leukemia cells. The large number of abnormal cells in the bone marrow interferes with the production of functional white blood cells, red blood cells, and platelets.
People with CBF-AML have a shortage of all types of mature blood cells: a shortage of white blood cells (leukopenia) leads to increased susceptibility to infections, a low number of red blood cells (anemia) causes fatigue and weakness, and a reduction in the amount of platelets (thrombocytopenia) can result in easy bruising and abnormal bleeding. Other symptoms of CBF-AML may include fever and weight loss.
While acute myeloid leukemia is generally a disease of older adults, CBF-AML often begins in young adulthood and can occur in childhood. Compared to other forms of acute myeloid leukemia, CBF-AML has a relatively good prognosis: about 90 percent of individuals with CBF-AML recover from their disease following treatment, compared with 25 to 40 percent of those with other forms of acute myeloid leukemia. However, the disease recurs in approximately half of them after successful treatment of the initial occurrence.
CBF-AML is associated with chromosomal rearrangements between chromosome 8 and chromosome 21 and within chromosome 16. The rearrangements involve the RUNX1, RUNX1T1, CBFB, and MYH11 genes. Two of these genes, RUNX1 and CBFB, provide instructions for making the two pieces of a protein complex known as core binding factor (CBF). CBF attaches to certain regions of DNA and turns on genes that help control the development of blood cells (hematopoiesis). In particular, it plays an important role in development of hematopoietic stem cells. Chromosomal rearrangements involving the RUNX1 or CBFB gene alter CBF, leading to leukemia.
In CBF-AML, the RUNX1 gene is affected by a type of genetic rearrangement known as a translocation; in this type of change, pieces of DNA from two chromosomes break off and are interchanged. The most common translocation in this condition, called t(8;21), fuses a part of the RUNX1 gene on chromosome 21 with part of the RUNX1T1 gene (also known as ETO) on chromosome 8. The combination of these genes leads to production of the RUNX1-ETO fusion protein. This fusion protein is able to form CBF and attach to DNA, like the normal RUNX1 protein. However, because the function of the protein produced from the normal RUNX1T1 gene is to block gene activity, the abnormal CBF turns genes off instead of turning them on.
Other genetic rearrangements associated with CBF-AML alter the CBFB gene. One such rearrangement, called an inversion, involves breakage of a chromosome in two places; the resulting piece of DNA is reversed and reinserted into the chromosome. The inversion involved in CBF-AML (written as inv(16)) leads to the fusion of two genes on chromosome 16, CBFB and MYH11. Less commonly, a translocation involving chromosome 16, written as t(16;16), leads to the fusion of the same two genes. The protein produced from these genetic rearrangements is called CBFβ-MYH11. The fusion protein can form CBF, but it is thought that the presence of the MYH11 portion of the fusion protein prevents CBF from binding to DNA, impairing its ability to control gene activity. Alternatively, the MYH11 portion may interact with other proteins that prevent CBF from controlling gene activity.
The change in gene activity caused by alteration of CBF blocks the maturation (differentiation) of blood cells and leads to the production of abnormal myeloid blasts. However, a chromosomal rearrangement alone is usually not enough to cause leukemia; one or more additional genetic changes are needed for cancer to develop. The additional changes likely cause the immature cells to grow and divide uncontrollably, leading to the excess of myeloid blasts characteristic of CBF-AML.